Literature DB >> 19089513

Novel presentation of a familial pancreatic cancer syndrome.

Ajay V Maker1, James A Warth, Michael J Zinner.   

Abstract

INTRODUCTION: Earlier detection of pancreatic cancer may help identify patients for whom surgical intervention could provide cure or prolong life. In this article, we report the occurrence of breast cancer, melanoma, squamous cell carcinoma of the alveolar ridge, colon cancer, a desmoid tumor of the abdominal wall, and pancreatic adenocarcinoma in a 65-year-old woman. She was identified as having the familial atypical multiple mole melanoma-pancreatic cancer syndrome (FAMMM-PC) with a germline p16 mutation at amino acid position 15. DISCUSSION: Patients with this syndrome traditionally present with multiple nevi and melanoma, and a subset also present with other cancers, including pancreatic cancer; however, no FAMMM-PC patient has yet been described with this constellation of cancers, including squamous cell carcinoma of the alveolar ridge and a desmoid tumor. Recognition of the tumors this population of patients is susceptible to developing and their genetic associations can help guide the surgeon in screening, surveillance, and eventually prevention of many of these cancers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19089513     DOI: 10.1007/s11605-008-0780-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  19 in total

Review 1.  Impact of p16 expression on surgical management of malignant melanoma and pancreatic carcinoma.

Authors:  G J Bullock; J L Green; P L Baron
Journal:  Am J Surg       Date:  1999-01       Impact factor: 2.565

2.  Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical mole melanoma-pancreatic carcinoma syndrome.

Authors:  Henry T Lynch; Randall E Brand; David Hogg; Carolyn A Deters; Ramon M Fusaro; Jane F Lynch; Ling Liu; Joseph Knezetic; Norman J Lassam; Michael Goggins; Scott Kern
Journal:  Cancer       Date:  2002-01-01       Impact factor: 6.860

Review 3.  Screening for CDKN2A mutations in hereditary melanoma.

Authors:  A M Goldstein; M A Tucker
Journal:  J Natl Cancer Inst       Date:  1997-05-21       Impact factor: 13.506

Review 4.  Familial pancreatic cancer: a review.

Authors:  H T Lynch; T Smyrk; S E Kern; R H Hruban; C J Lightdale; S J Lemon; J F Lynch; L R Fusaro; R M Fusaro; P Ghadirian
Journal:  Semin Oncol       Date:  1996-04       Impact factor: 4.929

5.  Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden).

Authors:  H F Vasen; N A Gruis; R R Frants; P A van Der Velden; E T Hille; W Bergman
Journal:  Int J Cancer       Date:  2000-09-15       Impact factor: 7.396

6.  High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families.

Authors:  A Borg; T Sandberg; K Nilsson; O Johannsson; M Klinker; A Måsbäck; J Westerdahl; H Olsson; C Ingvar
Journal:  J Natl Cancer Inst       Date:  2000-08-02       Impact factor: 13.506

7.  CDKN2A germline mutations in familial pancreatic cancer.

Authors:  Detlef K Bartsch; Mercedes Sina-Frey; Sven Lang; Anja Wild; Berthold Gerdes; Peter Barth; Ralf Kress; Robert Grützmann; Mario Colombo-Benkmann; Andreas Ziegler; Stephan A Hahn; Matthias Rothmund; Harald Rieder
Journal:  Ann Surg       Date:  2002-12       Impact factor: 12.969

Review 8.  Inherited pancreatic cancer: surveillance and treatment strategies for affected families.

Authors:  S J Rulyak; T A Brentnall
Journal:  Pancreatology       Date:  2001       Impact factor: 3.996

9.  Characterization of the neoplastic phenotype in the familial atypical multiple-mole melanoma-pancreatic carcinoma syndrome.

Authors:  Stephen J Rulyak; Teresa A Brentnall; Henry T Lynch; Melissa A Austin
Journal:  Cancer       Date:  2003-08-15       Impact factor: 6.860

10.  Abrogation of the p16-retinoblastoma-cyclin D1 pathway in head and neck squamous cell carcinomas.

Authors:  Hun-Woong Park; Si-Youn Song; Tae-Jin Lee; Daewon Jeong; Tae-Yoon Lee
Journal:  Oncol Rep       Date:  2007-07       Impact factor: 3.906

View more
  2 in total

Review 1.  Screening for Pancreatic Cancer.

Authors:  Saowanee Ngamruengphong; Marcia Irene Canto
Journal:  Surg Clin North Am       Date:  2016-12       Impact factor: 2.741

Review 2.  Pancreatic solid cystic desmoid tumor: case report and literature review.

Authors:  Bin Xu; Ling-Hua Zhu; Jia-Guo Wu; Xian-Fa Wang; Erik Matro; Jun-Jun Ni
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.